Sanofi embarks on doc-training in Morocco to boost diabetes, epilepsy care

Tracy Staton In established markets, Big Pharma targets doctors to boost sales. In emerging markets, drugmakers train them. Directly. Several of the globe's biggest pharma companies ...

CEO Chris Viehbacher steers Sanofi clear of drugs for Alzheimer’s disease

Eric Palmer Any company that can develop a drug even partially effective against Alzheimer's disease will strike a gold mine. One analyst estimates the opportunity to be $ 20 ...

Sanofi CEO fires surprise torpedo at Alzheimer’s drug research

Ryan McBride Count Sanofi ($ SNY) out of the wild chase to develop Alzheimer's drugs, at least while the best line of attack against the memory-robbing disease remains unclear. ...

Sanofi downsizing in France drags on

Eric Palmer CEO Chris Viehbacher Sanofi CEO Chris Viehbacher has been openly critical of his research operation in Toulouse, France. He said the researchers are costing too ...

Sanofi at vanguard with new process for antimalarial drugs

Eric Palmer French drugmaker Sanofi ($ SNY) said today it is gearing up to produce tons of artemisinin, the key ingredient for antimalarial treatments. Artemisinin usually comes ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS